Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

Join PanCAN on Thursday, March 26, at 11 a.m. PT / 2 p.m. ET, for our Nutrition Month webinar. Our panel of special guests will talk about common nutritional challenges as well as leading-edge ...

It’s dark. It’s cold. It’s winter. For people living in many parts of the U.S., this trifecta may affect a person’s mood in different ways, including for some the onset of seasonal affective disorder ...

Editor’s Note: Michigan PurpleStride Chair Renee Clearman spoke with Community Engagement Senior Specialist Paula Mukherjee about her passion for PanCAN’s mission and excitement for PanCAN ...

The National Comprehensive Cancer Network ® is a group of leading cancer centers focused on improving cancer care for patients. The organization creates guidelines aimed to help healthcare ...

Estos son algunos consejos y opciones de alimentos para diabéticos que les ayudarán a satisfacer sus necesidades ...

For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...

BOSTON, MA., San Diego, CA., and Calgary, AB. – (September 26, 2023) – In an effort to continue accelerating new treatment options for people with pancreatic cancer, the Pancreatic Cancer Action ...

The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...